| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Chief Executive Officer, Director | Common Stock | 30K | $149K | $4.96 | Mar 9, 2023 | Direct |
| SEELOS THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 1.67K | Jan 4, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SEEL | SEELOS THERAPEUTICS, INC. | Jan 4, 2024 | 1 | $0 | 4 | Jan 8, 2024 | Director |
| ZVRA | ZEVRA THERAPEUTICS, INC. | Mar 9, 2023 | 1 | $42K | 4 | Mar 13, 2023 | Chief Executive Officer, Director |
| ZVRA | KEMPHARM, INC | Jan 13, 2023 | 1 | $51.7K | 4 | Jan 13, 2023 | Chief Executive Officer, Director |
| ZVRA | KEMPHARM, INC | Jan 9, 2023 | 1 | $0 | 4 | Jan 11, 2023 | Chief Executive Officer, Director |
| SEEL | SEELOS THERAPEUTICS, INC. | Jan 5, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
| ZVRA | KEMPHARM, INC | May 18, 2022 | 7 | $24.6K | 4 | May 18, 2022 | Executive Chairman, Director |
| ZVRA | KEMPHARM, INC | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | Executive Chairman, Director |
| SEEL | SEELOS THERAPEUTICS, INC. | Jan 5, 2022 | 1 | $0 | 4 | Jan 6, 2022 | Director |
| ZVRA | KEMPHARM, INC | Nov 30, 2021 | 1 | $11.8K | 4 | Nov 30, 2021 | Executive Chairman, Director |
| ZVRA | KEMPHARM, INC | Nov 10, 2021 | 1 | $0 | 4 | Nov 10, 2021 | Executive Chairman, Director |
| ZVRA | KEMPHARM, INC | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |